Victoria Allgood

1.2k total citations
22 papers, 925 citations indexed

About

Victoria Allgood is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Victoria Allgood has authored 22 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Genetics. Recurrent topics in Victoria Allgood's work include Estrogen and related hormone effects (6 papers), Hormonal Regulation and Hypertension (4 papers) and CAR-T cell therapy research (3 papers). Victoria Allgood is often cited by papers focused on Estrogen and related hormone effects (6 papers), Hormonal Regulation and Hypertension (4 papers) and CAR-T cell therapy research (3 papers). Victoria Allgood collaborates with scholars based in United States, Canada and United Kingdom. Victoria Allgood's co-authors include John A. Cidlowski, Nancy L. Weigel, Frances E. Powell-Oliver, Yixian Zhang, Robert H. Oakley, Wenlong Bai, Douglas Β. Tully, Devalingam Mahalingam, Corinne M. Silva and Christine M. Jewell and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

Victoria Allgood

22 papers receiving 893 citations

Peers

Countries citing papers authored by Victoria Allgood

Since Specialization

Citations

This map shows the geographic impact of Victoria Allgood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Allgood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Allgood more than expected).

Fields of papers citing papers by Victoria Allgood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Allgood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Allgood. The network helps show where Victoria Allgood may publish in the future.

Co-authorship network of co-authors of Victoria Allgood

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Allgood. A scholar is included among the top collaborators of Victoria Allgood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Allgood. Victoria Allgood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and clinical activity of TTI-621 in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcoma: Results from the low-dose expansion cohort. 2023 ·Journal of Clinical Oncology ·Sujana Movva, Mihaela Druta, Lara E. Davis, Varun Monga, Mohammed Milhem, Howard H. Bailey, Rashmi Chugh, Ingmar Bruns, Victoria Allgood, Sant P. Chawla	9
2	TTI-621-03: A phase I/II study of TTI-621 in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcoma (LMS). 2022 ·Journal of Clinical Oncology ·Sant P. Chawla, Ciara M. Kelly, Erlinda M. Gordon, Doris Quon, (unknown), (unknown), (unknown), (unknown), (unknown), Victoria Allgood, Sujana Movva	4
3	A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma 2019 ·Cancers ·Devalingam Mahalingam, (unknown), Putao Cen, Sukeshi Patel Arora, John Sarantopoulos, Julie Rowe, Victoria Allgood, (unknown), Luis T. Campos	72
4	Mipsagargin, a PSMA-directed prodrug, provides clinical benefit in patients with advanced sorafenib-refractory hepatocellular carcinoma 2017 ·Journal of Hepatology ·Devalingam Mahalingam, (unknown), Putao Cen, Victoria Allgood, Ronald Shazer, Luis T. Campos	3
5	Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours 2016 ·British Journal of Cancer ·Devalingam Mahalingam, George Wilding, Samuel R. Denmeade, (unknown), David Cosgrove, Jeremy Cetnar, Nilofer S. Azad, Justine Y. Bruce, Michael R. Kurman, Victoria Allgood, Michael A. Carducci	123
6	ATCT-18PHASE II STUDY OF MIPSAGARGIN (G-202), A PSMA-ACTIVATED PRODRUG TARGETING THE TUMOR ENDOTHELIUM, IN ADULT PATIENTS WITH RECURRENT OR PROGRESSIVE GLIOBLASTOMA 2015 ·Neuro-Oncology ·David Piccioni, Tiffany Juarez, (unknown), (unknown), Victoria Allgood, Santosh Kesari	6
7	Clinical activity and correlative DCE-MRI imaging of G-202, a thapsigargin-based prostate-specific membrane antigen-activated prodrug, in progressive hepatocellular cancer. 2015 ·Journal of Clinical Oncology ·Devalingam Mahalingam, (unknown), John Nemunaitis, Putao Cen, Julie Rowe, John Sarantopoulos, Michael R. Kurman, Victoria Allgood, Luis T. Campos	3
8	Molecular Mechanisms in Cancer: What Should Clinicians Know? 2005 ·Seminars in Oncology ·Jaffer A. Ajani, Victoria Allgood	12
9	A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. 2003 ·PubMed ·Roy S. Herbst, Lisa A. Hammond, David P. Carbone, Hai T. Tran, Kenneth J. Holroyd, Avinash Desai, Jon I. Williams, B. Nebiyou Bekele, Howard Hait, Victoria Allgood, Stephen B. Solomon, Joan H. Schiller	41
10	Safety and Pharmacokinetic Effects of TNP-470, an Angiogenesis Inhibitor, Combined With Paclitaxel in Patients With Solid Tumors: Evidence for Activity in Non–Small-Cell Lung Cancer 2002 ·Journal of Clinical Oncology ·Roy S. Herbst, Timothy Madden, Hai T. Tran, George R. Blumenschein, Christina A. Meyers, (unknown), Fadlo R. Khuri, Vinay K. Puduvalli, Victoria Allgood, Herbert A. Fritsche, (unknown), Robert A. Newman, (unknown), Frank V. Fossella, Margaret S. Dordal, Thomas Goodin, Waun Ki Hong	84
11	Ocular Safety of INS365 Ophthalmic Solution: A P2Y ₂ Agonist In Healthy Subjects 2001 ·Journal of Ocular Pharmacology and Therapeutics ·(unknown), Gary D. Novack, Victoria Allgood, Richard Evans, (unknown), Benjamin R. Yerxa	25
12	Chimeric receptors as gene switches 1997 ·Current Opinion in Biotechnology ·Victoria Allgood, Eric Eastman	12
13	Differential Phosphorylation of Chicken Progesterone Receptor in Hormone-dependent and Ligand-independent Activation 1997 ·Journal of Biological Chemistry ·Wenlong Bai, Brian G. Rowan, Victoria Allgood, Bert W. O’Malley, Nancy L. Weigel	48
14	Analysis of Chicken Progesterone Receptor Function and Phosphorylation Using an Adenovirus-Mediated Procedure for High-Efficiency DNA Transfer 1997 ·Biochemistry ·Victoria Allgood, Yixian Zhang, (unknown), Nancy L. Weigel	53
15	Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid 1994 ·Steroids ·Corinne M. Silva, Frances E. Powell-Oliver, Christine M. Jewell, M. Sar, Victoria Allgood, John A. Cidlowski	103
16	Modulation of steroid receptor‐mediated gene expression by vitamin B ₆ 1994 ·The FASEB Journal ·Douglas Β. Tully, Victoria Allgood, John A. Cidlowski	59
17	Multiple signaling pathways activate the chicken progesterone receptor. 1994 ·Molecular Endocrinology ·Yixian Zhang, Wenlong Bai, Victoria Allgood, Nancy L. Weigel	66
18	Novel role for vitamin B6 in steroid hormone action: a link between nutrition and the endocrine system 1991 ·The Journal of Nutritional Biochemistry ·Victoria Allgood	7
19	The Influence of Vitamin B₆ on the Structure and Function of the Glucocorticoid Receptor^a 1990 ·Annals of the New York Academy of Sciences ·Victoria Allgood, Frances E. Powell-Oliver, John A. Cidlowski	16
20	Vitamin B6 influences glucocorticoid receptor-dependent gene expression. 1990 ·Journal of Biological Chemistry ·Victoria Allgood, Frances E. Powell-Oliver, John A. Cidlowski	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact